These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2769234)

  • 21. Immunogenicity of purified glycoprotein gB of herpes simplex virus.
    Kino Y; Eto T; Nishiyama K; Ohtomo N; Mori R
    Arch Virol; 1986; 89(1-4):69-80. PubMed ID: 3013134
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Induction of potent protection against acute and latent herpes simplex virus infection in mice vaccinated with dendritic cells.
    Ghasemi M; Erturk M; Buruk K; Sonmez M
    Cytotherapy; 2013 Mar; 15(3):352-61. PubMed ID: 23579060
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A comparison of oral and parenteral routes for therapeutic vaccination with HSV-2 ISCOMs in mice; cytokine profiles, antibody responses and protection.
    Mohamedi SA; Heath AW; Jennings R
    Antiviral Res; 2001 Feb; 49(2):83-99. PubMed ID: 11248361
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Purification of herpes simplex virus glycoproteins B and C using monoclonal antibodies and their ability to protect mice against lethal challenge.
    Roberts PL; Duncan BE; Raybould TJ; Watson DH
    J Gen Virol; 1985 May; 66 ( Pt 5)():1073-85. PubMed ID: 2582080
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Passive transfer of anti-herpes simplex virus type 2 monoclonal and polyclonal antibodies protect against herpes simplex virus type 1-induced but not herpes simplex virus type 2-induced stromal keratitis.
    Ritchie MH; Oakes JE; Lausch RN
    Invest Ophthalmol Vis Sci; 1993 Jul; 34(8):2460-8. PubMed ID: 8392037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Yeast-derived glycoprotein B-1 of herpes simplex virus (HSV) as a candidate for an HSV vaccine.
    Kino Y
    Adv Exp Med Biol; 1990; 278():183-90. PubMed ID: 1963033
    [No Abstract]   [Full Text] [Related]  

  • 27. Cholera toxin conjugates for intragastric vaccination against herpes simplex virus type 2.
    Drew MD; Estrada AE; Underdown BJ; McDermott MR
    Reg Immunol; 1992; 4(2):79-85. PubMed ID: 1503890
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Modified-self-induced modulation of the immune response to herpes simplex virus: effect on antibody formation, cytotoxic T lymphocyte induction, and survival.
    Wilson LA; Karabin JM; Smith JW; Dawson D; Scott DW
    J Immunol; 1984 Mar; 132(3):1522-8. PubMed ID: 6198395
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic immunization against herpes simplex virus. Protection is mediated by CD4+ T lymphocytes.
    Manickan E; Rouse RJ; Yu Z; Wire WS; Rouse BT
    J Immunol; 1995 Jul; 155(1):259-65. PubMed ID: 7602102
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Zwitterionic detergent solubilisation of HSV-1 surface antigens.
    Jennings R; Quasim T; Sharrard RM; Hockley D; Potter CW
    Arch Virol; 1988; 98(3-4):137-53. PubMed ID: 2831853
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Nasal and skin delivery of IC31(®)-adjuvanted recombinant HSV-2 gD protein confers protection against genital herpes.
    Wizel B; Persson J; Thörn K; Nagy E; Harandi AM
    Vaccine; 2012 Jun; 30(29):4361-8. PubMed ID: 22682292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroinvasive properties of herpes simplex virus type 1 glycoprotein variants are controlled by the immune response.
    Mitchell BM; Stevens JG
    J Immunol; 1996 Jan; 156(1):246-55. PubMed ID: 8598469
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mucosal and systemic antiviral antibodies in mice inoculated intravaginally with herpes simplex virus type 2.
    McDermott MR; Brais LJ; Evelegh MJ
    J Gen Virol; 1990 Jul; 71 ( Pt 7)():1497-504. PubMed ID: 2165134
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of in vivo depletion of immunocyte populations on herpes simplex virus glycoprotein D vaccine-induced resistance to HSV2 challenge.
    Mishkin EM; Blasiak M; Giorgio D; Ishizaka ST
    Viral Immunol; 1992; 5(2):151-61. PubMed ID: 1319710
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Humoral response to HSV-1 subunit vaccines--a statistical analysis.
    Simms JR; Heath AW; Richardson VJ; Jennings R
    Dev Biol Stand; 1998; 92():335-40. PubMed ID: 9554289
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virus neutralizing activity induced by synthetic peptides of glycoprotein D of herpes simplex virus type 1, selected by their reactivity with hyperimmune sera from mice.
    Geerligs HJ; Kocken CH; Drijfhout JW; Weijer WJ; Bloemhoff W; Wilterdink JB; Welling GW; Welling-Wester S
    J Gen Virol; 1990 Aug; 71 ( Pt 8)():1767-74. PubMed ID: 2167930
    [TBL] [Abstract][Full Text] [Related]  

  • 37. An adenovirus-herpes simplex virus glycoprotein B recombinant (Ad-HSV.gB) protects mice against a vaccinia HSV.gB and HSV challenge.
    Endresz V; Berencsi K; Gönczöl E
    Acta Microbiol Immunol Hung; 1995; 42(3):247-54. PubMed ID: 8548197
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A novel DNA vaccine technology conveying protection against a lethal herpes simplex viral challenge in mice.
    Dutton JL; Li B; Woo WP; Marshak JO; Xu Y; Huang ML; Dong L; Frazer IH; Koelle DM
    PLoS One; 2013; 8(10):e76407. PubMed ID: 24098493
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Analysis of protective immune responses to the glycoprotein H-glycoprotein L complex of herpes simplex virus type 1.
    Browne H; Baxter V; Minson T
    J Gen Virol; 1993 Dec; 74 ( Pt 12)():2813-7. PubMed ID: 8277292
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cytokine genetic adjuvant facilitates prophylactic intravascular DNA vaccine against acute and latent herpes simplex virus infection in mice.
    Cui FD; Asada H; Jin ML; Kishida T; Shin-Ya M; Nakaya T; Kita M; Ishii M; Iwai M; Okanoue T; Imanishi J; Mazda O
    Gene Ther; 2005 Jan; 12(2):160-8. PubMed ID: 15470476
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.